Global Organ Preservation Market
The organ preservation market encompasses products, technologies, and services designed to maintain the viability of organs outside the human body for transplantation purposes. This market is critical for the success of organ transplants, ensuring that organs remain functional from the time of harvesting until they are transplanted into the recipient. Here’s an overview of the organ preservation market:
Market Overview
Market Size and Growth:
The organ preservation market is growing steadily due to increasing incidences of organ failure, advancements in preservation techniques, and rising demand for organ transplants.
Growth is driven by technological innovations, increasing awareness about organ donation, and government initiatives to support transplantation programs.
Key Product Segments:
Solutions: Preservation solutions used to maintain organ viability, such as University of Wisconsin (UW) solution, Custodiol HTK, and Perfadex.
Equipment: Devices used for the transportation and preservation of organs, including hypothermic and normothermic perfusion systems.
Services: Logistics and transportation services, as well as storage facilities that support the preservation and distribution of organs.
Regional Analysis
North America:
Market Characteristics: Largest market due to advanced healthcare infrastructure, high number of organ transplants, and strong support for organ donation.
Key Drivers: High prevalence of chronic diseases leading to organ failure, robust organ donation programs, and significant investment in R&D.
Key Players: Paragonix Technologies, TransMedics, and XVIVO Perfusion.
Trends: Increasing use of machine perfusion techniques, growing investment in organ transplant research, and rising awareness campaigns for organ donation.
Europe:
Market Characteristics: Significant market with well-established organ donation and transplantation systems.
Key Drivers: High incidence of organ failure, strong healthcare policies supporting transplantation, and advancements in preservation technology.
Key Players: Bridge to Life, OrganOx, and Dr. Franz Köhler Chemie GmbH.
Trends: Expansion of preservation facilities, increasing adoption of advanced perfusion technologies, and collaborative initiatives to enhance organ donation rates.
Asia-Pacific:
Market Characteristics: Fastest-growing market due to increasing healthcare expenditure, rising awareness about organ donation, and improving healthcare infrastructure.
Key Drivers: Growing incidence of organ failure, increasing investment in healthcare infrastructure, and rising number of transplantation surgeries.
Key Players: Biochefa, Institut Georges Lopez (IGL), and China Organ Transplantation Development Foundation.
Trends: Government initiatives to promote organ donation, adoption of innovative preservation methods, and expansion of transplant centers.
Latin America:
Market Characteristics: Emerging market with growing potential due to increasing organ donation awareness and improving healthcare systems.
Key Drivers: Rising prevalence of chronic diseases, improving healthcare access, and increasing support for organ transplantation programs.
Key Players: Local healthcare providers and global companies expanding into the region.
Trends: Increasing collaborations between local and international organizations, development of regional preservation and transplant centers, and growing use of preservation solutions.
Middle East and Africa:
Market Characteristics: Developing market with improving healthcare infrastructure and rising awareness about organ transplantation.
Key Drivers: High incidence of organ failure, increasing healthcare investments, and initiatives to improve organ donation rates.
Key Players: Regional healthcare providers and international companies entering the market.
Trends: Gradual adoption of advanced preservation technologies, government efforts to enhance organ donation, and improving logistics and transportation services.
Market Drivers
Increasing Organ Failure Incidence: Rising prevalence of chronic diseases such as diabetes, hypertension, and liver diseases leading to organ failure.
Advancements in Preservation Technology: Technological innovations improving the efficiency and effectiveness of organ preservation methods.
Rising Demand for Organ Transplants: Growing number of patients requiring organ transplants driving the need for effective preservation solutions.
Government Initiatives: Supportive policies and programs promoting organ donation and transplantation.
Awareness Campaigns: Increasing public awareness about the importance of organ donation.
Challenges
Shortage of Donors: Limited availability of donor organs compared to the high demand for transplants.
Ethical and Legal Issues: Ethical concerns and varying legal frameworks regarding organ donation and transplantation.
High Costs: Expensive preservation solutions and technologies, limiting access in low-resource settings.
Logistical Challenges: Complexities in the transportation and storage of organs, requiring advanced logistics and infrastructure.
Technical Limitations: Limitations in current preservation techniques affecting the viability and longevity of preserved organs.
Future Trends
Machine Perfusion Technologies: Increasing adoption of normothermic and hypothermic machine perfusion techniques to enhance organ preservation.
Regenerative Medicine: Advances in regenerative medicine and tissue engineering potentially reducing the dependency on donor organs.
Telemedicine and Remote Monitoring: Integration of telemedicine and remote monitoring technologies to optimize organ preservation and transplantation processes.
Global Collaboration: International collaboration to address organ donation shortages and improve preservation methods.
Sustainable Preservation Solutions: Development of eco-friendly and sustainable preservation solutions and technologies.
The organ preservation market is poised for significant growth, driven by technological advancements, increasing demand for organ transplants, and supportive government initiatives. The future will likely see further innovations in preservation techniques, expanded global collaboration, and improved logistics to enhance the efficiency and success of organ transplantation.
| Report AttributesA2:B10+A2:B12A2:B10A2:B9B8A2:B11A2:B8 | Details |
| Study Period | 2023 to 2033 |
| Base Year | 2023 |
| FORECAST PERIOD | 2024-2030 |
| HISTORICAL PERIOD | 2020-2023 |
| UNIT | Value (USD Billion) |
| KEY COMPANIES PROFILED | • XVIVO Perfusion AB • TransMedics Inc. • Organ Recovery Systems Inc. • Preservation Solutions Inc. • Bridge to Life Ltd. • Franz Köhler Chemie GmbH • Paragonix Technologies Inc. • BioLife Solutions Inc. • Waters Medical Systems LLC • XVIVO Perfusion Inc. • OrganOx Limited • Organ Assist B.V. • Preservation Solutions Inc. • 21st Century Medicine • Transplant Biomedicals S.L. • Others |
| SEGMENTS COVERED | By Type, By Application, and By Geography |
| CUSTOMIZATION SCOPE | Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Organ Preservation Market Segments
By Type
· Static Cold Storage (SCS)
· Hypothermic Machine Perfusion (HMP)
· Normothermic Machine Perfusion (NMP)
· Others
By Organ
· Kidney
· Liver
· Heart
· Lung
· Others
By Preservation Solution
· Intracellular Solutions
· Extracellular Solutions
· Colloids
· Others
By End User
· Hospitals
· Organ Banks
· Tissue Banks
· Others
Organ Preservation Market Players
· XVIVO Perfusion AB
· TransMedics Inc.
· Organ Recovery Systems Inc.
· Preservation Solutions Inc.
· Bridge to Life Ltd.
· Franz Köhler Chemie GmbH
· Paragonix Technologies Inc.
· BioLife Solutions Inc.
· Waters Medical Systems LLC
· XVIVO Perfusion Inc.
· OrganOx Limited
· Organ Assist B.V.
· Preservation Solutions Inc.
· 21st Century Medicine
· Transplant Biomedicals S.L.
· Others
Table of Contents
Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market Research Methodology
Chapter 2. Executive Summary
2.1 Global Organ Preservation Market, (2024 – 2033) (USD Million)
2.2 Global Organ Preservation Market: snapshot
Chapter 3. Global Organ Preservation Market – Industry Analysis
3.1 Organ Preservation Market: Market Dynamics
3.2 Market Drivers
3.2.1 Increasing Demand for Organ Transplants
3.2.2 Advancements in Preservation Techniques
3.2.3 Growing Organ Donation Networks
3.2.4 Rising Healthcare Expenditure and Research Investments
3.2.5 Technological Advancements and Product Innovation.
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Organ
3.7.3 Market Attractiveness Analysis By Preservation Solution
3.7.4 Market Attractiveness Analysis By End User
Chapter 4. Global Organ Preservation Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Organ Preservation Market: Company Market Share, 2023
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
Chapter 5. Global Organ Preservation Market – Type Analysis
5.1 Global Organ Preservation Market Overview: By Type
5.1.1 Global Organ Preservation Market Share, By Type, 2023 and 2033
5.2 Static Cold Storage (SCS)
5.2.1 Global Organ Preservation Market by Static Cold Storage (SCS), 2024 – 2033 (USD Million)
5.3 Hypothermic Machine Perfusion (HMP)
5.3.1 Global Organ Preservation Market by Hypothermic Machine Perfusion (HMP), 2024 – 2033 (USD Million)
5.4 Normothermic Machine Perfusion (NMP)
5.4.1 Global Organ Preservation Market by Normothermic Machine Perfusion (NMP), 2024 – 2033 (USD Million)
5.5 Others
5.5.1 Global Organ Preservation Market by Others, 2024 – 2033 (USD Million)
Chapter 6. Global Organ Preservation Market – Organ Analysis
6.1 Global Organ Preservation Market Overview: By Organ
6.1.1 Global Organ Preservation Market Share, By Organ, 2023 and 2033
6.2 Kidney
6.2.1 Global Organ Preservation Market by Kidney, 2024 – 2033 (USD Million)
6.3 Liver
6.3.1 Global Organ Preservation Market by Liver, 2024 – 2033 (USD Million)
6.4 Heart
6.4.1 Global Organ Preservation Market by Heart, 2024 – 2033 (USD Million)
6.5 Lung
6.5.1 Global Organ Preservation Market by Lung, 2024 – 2033 (USD Million)
6.6 Others
6.6.1 Global Organ Preservation Market by Others, 2024 – 2033 (USD Million)
Chapter 7. Global Organ Preservation Market – Preservation Solution Analysis
7.1 Global Organ Preservation Market Overview: By Preservation Solution
7.1.1 Global Organ Preservation Market Share, By Preservation Solution, 2023 and 2033
7.2 Intracellular Solutions
7.2.1 Global Organ Preservation Market by Intracellular Solutions, 2024 – 2033 (USD Million)
7.3 Extracellular Solutions
7.3.1 Global Organ Preservation Market by Extracellular Solutions, 2024 – 2033 (USD Million)
7.4 Colloids
7.4.1 Global Organ Preservation Market by Colloids, 2024 – 2033 (USD Million)
7.5 Others
7.5.1 Global Organ Preservation Market by Others, 2024 – 2033 (USD Million)
Chapter 8. Global Organ Preservation Market – End User Analysis
8.1 Global Organ Preservation Market Overview: By End User
8.1.1 Global Organ Preservation Market Share, By End User, 2023 and 2033
8.2 Hospitals
8.2.1 Global Organ Preservation Market by Hospitals, 2024 – 2033 (USD Million)
8.3 Organ Banks
8.3.1 Global Organ Preservation Market by Organ Banks, 2024 – 2033 (USD Million)
8.4 Tissue Banks
8.4.1 Global Organ Preservation Market by Tissue Banks, 2024 – 2033 (USD Million)
8.5 Others
8.5.1 Global Organ Preservation Market by Others, 2024 – 2033 (USD Million)
Chapter 9. Organ Preservation Market – Regional Analysis
9.1 Global Organ Preservation Market Regional Overview
9.2 Global Organ Preservation Market Share, by Region, 2023 & 2033 (USD Million)
9.3. North America
9.3.1 North America Organ Preservation Market, 2024 – 2033 (USD Million)
9.3.1.1 North America Organ Preservation Market, by Country, 2024 – 2033 (USD Million)
9.4 North America Organ Preservation Market, by Type, 2024 – 2033
9.4.1 North America Organ Preservation Market, by Type, 2024 – 2033 (USD Million)
9.5 North America Organ Preservation Market, by Organ, 2024 – 2033
9.5.1 North America Organ Preservation Market, by Organ, 2024 – 2033 (USD Million)
9.6 North America Organ Preservation Market, by Preservation Solution, 2024 – 2033
9.6.1 North America Organ Preservation Market, by Preservation Solution, 2024 – 2033 (USD Million)
9.7 North America Organ Preservation Market, by End User, 2024 – 2033
9.7.1 North America Organ Preservation Market, by End User, 2024 – 2033 (USD Million)
9.8. Europe
9.8.1 Europe Organ Preservation Market, 2024 – 2033 (USD Million)
9.8.1.1 Europe Organ Preservation Market, by Country, 2024 – 2033 (USD Million)
9.9 Europe Organ Preservation Market, by Type, 2024 – 2033
9.9.1 Europe Organ Preservation Market, by Type, 2024 – 2033 (USD Million)
9.10 Europe Organ Preservation Market, by Organ, 2024 – 2033
9.10.1 Europe Organ Preservation Market, by Organ, 2024 – 2033 (USD Million)
9.11 Europe Organ Preservation Market, by Preservation Solution, 2024 – 2033
9.11.1 Europe Organ Preservation Market, by Preservation Solution, 2024 – 2033 (USD Million)
9.12 Europe Organ Preservation Market, by End User, 2024 – 2033
9.12.1 Europe Organ Preservation Market, by End User, 2024 – 2033 (USD Million)
9.13. Asia Pacific
9.13.1 Asia Pacific Organ Preservation Market, 2024 – 2033 (USD Million)
9.13.1.1 Asia Pacific Organ Preservation Market, by Country, 2024 – 2033 (USD Million)
9.14 Asia Pacific Organ Preservation Market, by Type, 2024 – 2033
9.14.1 Asia Pacific Organ Preservation Market, by Type, 2024 – 2033 (USD Million)
9.15 Asia Pacific Organ Preservation Market, by Organ, 2024 – 2033
9.15.1 Asia Pacific Organ Preservation Market, by Organ, 2024 – 2033 (USD Million)
9.16 Asia Pacific Organ Preservation Market, by Preservation Solution, 2024 – 2033
9.16.1 Asia Pacific Organ Preservation Market, by Preservation Solution, 2024 – 2033 (USD Million)
9.17 Asia Pacific Organ Preservation Market, by End User, 2024 – 2033
9.17.1 Asia Pacific Organ Preservation Market, by End User, 2024 – 2033 (USD Million)
9.18. Latin America
9.18.1 Latin America Organ Preservation Market, 2024 – 2033 (USD Million)
9.18.1.1 Latin America Organ Preservation Market, by Country, 2024 – 2033 (USD Million)
9.19 Latin America Organ Preservation Market, by Type, 2024 – 2033
9.19.1 Latin America Organ Preservation Market, by Type, 2024 – 2033 (USD Million)
9.20 Latin America Organ Preservation Market, by Organ, 2024 – 2033
9.20.1 Latin America Organ Preservation Market, by Organ, 2024 – 2033 (USD Million)
9.21 Latin America Organ Preservation Market, by Preservation Solution, 2024 – 2033
9.21.1 Latin America Organ Preservation Market, by Preservation Solution, 2024 – 2033 (USD Million)
9.22 Latin America Organ Preservation Market, by End User, 2024 – 2033
9.22.1 Latin America Organ Preservation Market, by End User, 2024 – 2033 (USD Million)
9.23. The Middle-East and Africa
9.23.1 The Middle-East and Africa Organ Preservation Market, 2024 – 2033 (USD Million)
9.23.1.1 The Middle-East and Africa Organ Preservation Market, by Country, 2024 – 2033 (USD Million)
9.24 The Middle-East and Africa Organ Preservation Market, by Type, 2024 – 2033
9.24.1 The Middle-East and Africa Organ Preservation Market, by Type, 2024 – 2033 (USD Million)
9.25 The Middle-East and Africa Organ Preservation Market, by Organ, 2024 – 2033
9.25.1 The Middle-East and Africa Organ Preservation Market, by Organ, 2024 – 2033 (USD Million)
9.26 The Middle-East and Africa Organ Preservation Market, by Preservation Solution, 2024 – 2033
9.26.1 The Middle-East and Africa Organ Preservation Market, by Preservation Solution, 2024 – 2033 (USD Million)
9.27 The Middle-East and Africa Organ Preservation Market, by End User, 2024 – 2033
9.27.1 The Middle-East and Africa Organ Preservation Market, by End User, 2024 – 2033 (USD Million)
Chapter 10. Company Profiles
10.1 XVIVO Perfusion AB
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Business Strategy
10.1.5 Recent Developments
10.2 TransMedics Inc.
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Business Strategy
10.2.5 Recent Developments
10.3 Organ Recovery Systems Inc.
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Business Strategy
10.3.5 Recent Developments
10.4 Preservation Solutions Inc.
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Business Strategy
10.4.5 Recent Developments
10.5 Bridge to Life Ltd.
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Business Strategy
10.5.5 Recent Developments
10.6 Dr. Franz Köhler Chemie GmbH
10.6.1 Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Business Strategy
10.6.5 Recent Developments
10.7 Paragonix Technologies Inc.
10.7.1 Overview
10.7.2 Financials
10.7.3 Product Portfolio
10.7.4 Business Strategy
10.7.5 Recent Developments
10.8 BioLife Solutions Inc.
10.8.1 Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Business Strategy
10.8.5 Recent Developments
10.9 Waters Medical Systems LLC
10.9.1 Overview
10.9.2 Financials
10.9.3 Product Portfolio
10.9.4 Business Strategy
10.9.5 Recent Developments
10.10 XVIVO Perfusion Inc.
10.10.1 Overview
10.10.2 Financials
10.10.3 Product Portfolio
10.10.4 Business Strategy
10.10.5 Recent Developments
10.11 OrganOx Limited
10.11.1 Overview
10.11.2 Financials
10.11.3 Product Portfolio
10.11.4 Business Strategy
10.11.5 Recent Developments
10.12 Organ Assist B.V.
10.12.1 Overview
10.12.2 Financials
10.12.3 Product Portfolio
10.12.4 Business Strategy
10.12.5 Recent Developments
10.13 Preservation Solutions Inc.
10.13.1 Overview
10.13.2 Financials
10.13.3 Product Portfolio
10.13.4 Business Strategy
10.13.5 Recent Developments
10.14 21st Century Medicine
10.14.1 Overview
10.14.2 Financials
10.14.3 Product Portfolio
10.14.4 Business Strategy
10.14.5 Recent Developments
10.15 Transplant Biomedicals S.L.
10.15.1 Overview
10.15.2 Financials
10.15.3 Product Portfolio
10.15.4 Business Strategy
10.15.5 Recent Developments
10.16 Others.
10.16.1 Overview
10.16.2 Financials
10.16.3 Product Portfolio
10.16.4 Business Strategy
10.16.5 Recent Developments
Organ Preservation Market Segments
By Type
· Static Cold Storage (SCS)
· Hypothermic Machine Perfusion (HMP)
· Normothermic Machine Perfusion (NMP)
· Others
By Organ
· Kidney
· Liver
· Heart
· Lung
· Others
By Preservation Solution
· Intracellular Solutions
· Extracellular Solutions
· Colloids
· Others
By End User
· Hospitals
· Organ Banks
· Tissue Banks
· Others
Organ Preservation Market Players
· XVIVO Perfusion AB
· TransMedics Inc.
· Organ Recovery Systems Inc.
· Preservation Solutions Inc.
· Bridge to Life Ltd.
· Franz Köhler Chemie GmbH
· Paragonix Technologies Inc.
· BioLife Solutions Inc.
· Waters Medical Systems LLC
· XVIVO Perfusion Inc.
· OrganOx Limited
· Organ Assist B.V.
· Preservation Solutions Inc.
· 21st Century Medicine
· Transplant Biomedicals S.L.
Others
